Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

SRPT - Sarepta Therapeutics, Inc. Financial... | Finranks

Home

/

SRPT

S

Sarepta Therapeutics, Inc. (SRPT)

NMS – Real Time Price. Currency in USD

18.32

+0.10 (0.56%)

Market open: Aug 12, 2026, 11:39 AM EDT

18.33

+0.11 (0.61%)

Previous after-hours: Aug 11, 2026, 7:45 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

2.20B

1.90B

1.24B

933M

Cost of goods sold

-884M

-357M

-195M

-182M

Gross Profit

1.31B

1.55B

1.05B

751M

Operating expenses (excl. COGS)

-1.97B

-1.33B

-1.32B

-1.28B

Operating Income

-658M

218M

-268M

-530M

Non-operating income, total

-44M

43M

-252M

-160M

Pretax income

-702M

261M

-520M

-690M

Equity in earnings

0

0

0

0

Taxes

-11M

-26M

-16M

-14M

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-713M

235M

-536M

-703M

Discontinued operations

0

0

0

0

Net income

-713M

235M

-536M

-703M

Dilution adjustment

0

17M

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

3.35B-15.5%

3.96B+21.4%

3.26B+4.4%

3.13B

Total current assets

2.54B

3.07B

2.58B

2.56B

Total non-current assets

812M

890M

685M

571M

Total liabilities

2.21B-9.3%

2.44B+1.3%

2.41B-12.3%

2.74B

Total current liabilities

1.10B

732M

654M

620M

Total non-current liabilities

1.11B

1.70B

1.75B

2.12B

Total equity

1.14B

1.53B

859M

385M

Total liabilities & shareholders' equities

3.35B

3.96B

3.26B

3.13B

Total debt

1.04B-22.6%

1.34B-3.9%

1.40B-13.6%

1.62B

Name

2025

2024

2023

2022

Cash from operating activities

-223M

-206M

-501M

-325M

Cash from investing activities

70M

756M

-166M

-1.05B

Cash from financing activities

-151M

125M

125M

233M

Free cash flow

-325M+5.3%

-343M+40.6%

-577M-62.0%

-356M